Expert perspectives on LBAs for %FULLNAME%

Oncology Digest

HIGHLIGHTS

The role of SSA at progression - to continue or not?

This podcast explores therapeutic decision making for patients at progression for people living with NETs. The experts analyse data from prospective studies NETTER-1, CLARINET FORTE and REMINET.

Systemic therapy in endometrial carcinoma: the nurses' perspective

Experts in gynae-oncology nursing provide insights on treatment with systemic therapies and how to navigate side effects.

Clinical implementation of targeted and immunotherapies for advanced RCC

The experts discuss the use of targeted and immunotherapies in the therapeutic strategy for advanced RCC patients and the importance of managing toxicities through dose modification and education.

Shared decision-making in nmCRPC

This podcast gives both nurse and physician views on the importance of shared decision-making for nmCRPC patients and key considerations for treatment selection including adverse event management and drug interactions.

Learn of Other Programmes in Oncology

Optimising treatment sequencing for mCRC, third line and beyond

How can oncology practitioners optimise treatment sequencing for patients with metastatic colorectal cancer (mCRC), third line and beyond?

Publication Snapshot: Regorafenib for the Treatment of Sarcoma

Listen as Professor Robert Maki discusses regorafenib as a potential therapy in sarcoma in this review of clinical trials.

Prof. Robert Maki US

This email is from COR2ED as a provider of independent and medical education and not in the pursuit of any commercial interest. You receive this email as a healthcare professional with expertise In one or more topics covered by COR2ED's educational programmes, to help inform your clinical practice with the aim of improving the overall health of patients. The material and content contained and accessed via this newsletter are for healthcare professionals only. By visiting our websites you acknowledge COR2ED's Privacy Policy. Although every effort is made to ensure that the material within this newsletter is accurate and timely, it is provided for informational and educational purposes only. The information provided via this newsletter is not a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country. The views are the personal opinions of the experts. They do not necessarily represent the views of the expert's academic institution, employer, organisation, or other group or individual.

You receive this email as a healthcare professional with expertise and knowledge in this topic or therapeutic area. If you wish to unsubscribe from entails of this type,
please feel free to unsubscribe below.